Member Info for mact4

Good luck.

We do have a few minor resistance lines to break first, but as other posters have said, we reached £258 last year so once this is breached, 300-325 is the FIRST target.
Assuming good Sprinter results, I am expecting the SP to 'step-ladder' up, even allowing for 'gap-up'.
Patience still required.

With a breakout of a consolidation triangle, based on the size of the triangle, minimum FIRST target set at 300-325

Change of topic please

Becontrarian

I understand your thinking.

Problem is the very contagious nature of Covid19. In a local primary school, over half the teachers went down like skittles due to Covid. They were poorly, though all were vaccinated and one ended up in hospital briefly. All made a recovery but have a few lingering issues.

Most had children in the local secondary who brought it home and infected their families. Some cross infection happened on the school grounds.

Vaccination was never the complete answer. However, it does save lives. More importantly, it also bought time to try to get more effective therapeutics onto the market.

I remember reading that in the future the flu and Covid 19 vaccs may be combined into one, and even then, perhaps only for the older population or the clinically vulnerable; because it will be very hard to persuade the general population to keep being vaccinated, year in and year out.

Wishing you well, Woody.

Hope you'll soon be back and contributing in these exciting times.

Very good point, Violet.

Kiwi,
I am just ignoring non-SNG related comments now.
Entrenched views will not change. It is just a waste of time and space.

I am going to RESPECT that this is an SNG chat board.

Raphaking

I would draw the top line of the triangle from the high on 15/2/ 2021 and join the the next high at 15/6/2021
You will then see that today is a breakout from this top trend line.
This triangle corresponds to an Elliot Wave triangle formation, forecasting a breakout from the last low.4/10/2021

Lots of possible targets with Fibonacci confluence. With good to excellent P3 results and/or preorders, I expect to successive higher highs, like a step ladder formation

Lloyd - I believe it is a case of news of progression A2 P2-P3, hitting the wider market, so more retail investors may be piling in both here and perhaps across the pond.

Other investors may have been on the sidelines and with A2 progression news, the share is deemed less risky.

And finally - FOMO may have kicked in.

From a chartist perspective, the Triangle pattern had reached what is known as Wave E (last low), so the only direction was upwards, with a breakout of the triangle pattern.

FTC - You weren't the only one but I thank you; for me, apologies accepted.

Because of course, you should be able to say what you want, when you want, never mind how offensive it is to others.

Because of course, you do not have any female relatives or friends to whom you care enough about, to stand up and speak on their behalf.

Never mind all that.

Maybe you can at least respect that this is a BB for Synairgen and not as Kiwi aptly puts it, a men's club.

It's not overbought on the Daily yet, on the hourly, yes but the indicators can stay overbought for quite a while. No confirmed sign of divergence yet, either.

Oakleaf - no, just a rehash of the RNS but surprisingly beneficial to my blood pressure after listening to Javid ;-)

https://www.stockmarketwire.com/article/7219381/Synairgen-treatment-for-Covid-given-safety-nod-for-phase-three-trial.html
https://www.marketwatch.com/story/synairgen-coronavirus-treatment-recommended-for-phase-3-trials-271634712816
https://www.evaluate.com/vantage/articles/news/snippets/nih-endorsement-boosts-synairgen-critical-readout-approaches
https://www.sharesmagazine.co.uk/news/shares/minister-rules-out-fresh-uk-lockdown-but-ftse-100-struggles-for-direction

And by opening our borders we are exporting these variants!

Completely get where you're coming from. Sitain.

Unfortunately, the world of pharma, scientists and politicians is as murky as a swamp. You only have to look at Prof H's tweet to see how vested interests and personal egos can deny entrance to potentially life-saving treatments.

For now, I am just going to enjoy this RNS confirmation. It helps that it comes less than 24 hours after that tweet - talk about having egg in one's face.

Vindicated RM and the BoD (not that they needed vindication...) with their recent high profile key appointments. Forward thinking of what?!

With no access to data yet, SP is muted but I would expect further upside to the SP over the next few hours/days as more information becomes available.
Confirmed progression to A2P3 has derisked this share further.

Of all the speculated reasons for the delays to announcing progress to A2P3, I did not expect that to be because Synairgen did not receive any data. This is contrary to their own Protocol. I wonder why.

Excellent news, long awaited.

Take that Prof H!